Estrogens are present in both men and women, but they are usually present at significantly higher levels in women of reproductive age. Estrogen (Pic.1) is the reproductive hormone in females that assists in endometrial regrowth, ovulation, and calcium absorption; it is also responsible for the secondary sexual characteristics of females. These include breast development, flaring of the hips, and a shorter period necessary for bone maturation.
In males, estrogen regulates certain functions of the reproductive system important to the maturation of sperm and may be necessary for a healthy libido. Furthermore, there are several other structural changes induced by estrogen in addition to other functions.
Synthetic estrogens are used as part of some oral contraceptives, in estrogen replacement therapy for postmenopausal women, and in hormone replacement therapy for trans women.
Production and regulation
Estrogens, in females, are produced primarily by the ovaries, and during pregnancy, the placenta. Follicle-stimulating hormone (FSH) stimulates the ovarian production of estrogens. Some estrogens are also produced in smaller amounts by other tissues such as the liver, adrenal glands, and the breasts. These secondary sources of estrogens are especially important in postmenopausal women. Fat cells produce estrogen as well.
In females, synthesis of estrogens starts in theca interna cells in the ovary, by the synthesis of androstenedione from cholesterol. This compound crosses the basal membrane into the surrounding granulosa cells, where it is converted either immediately into estrone, or into testosterone and then estradiol in an additional step. Both granulosa and theca cells are essential for the production of estrogen in the ovaries.
Estrogen levels vary through the menstrual cycle, with levels highest near the end of the follicular phase just before ovulation.
Estrogen, in male, is synthesized by Leydig cells (produce testosterone) and the germ cells, producing a relatively high concentration in rete testis fluid.
Menstrual cycle and ovulation
The menstrual cycle is governed by hormonal changes. Each cycle can be divided into three phases based on events in the ovary (ovarian cycle) or in the uterus (uterine cycle). The ovarian cycle consists of the follicular phase, ovulation, and luteal phase whereas the uterine cycle is divided into menstruation, proliferative phase, and secretory phase.
Stimulated by gradually increasing amounts of estrogen in the follicular phase, discharges of blood (menses) flow stop, and the lining of the uterus thickens. Follicles in the ovary begin developing under the influence of a complex interplay of hormones, and after several days one or occasionally two become dominant (non-dominant follicles shrink and die). Approximately mid-cycle, 24–36 hours after the luteinizing hormone (LH) surges, the dominant follicle releases an ovocyte, in an event called ovulation. After ovulation, the ovocyte only lives for 24 hours or less without fertilization while the remains of the dominant follicle in the ovary become a corpus luteum; this body has a primary function of producing large amounts of progesterone. Under the influence of progesterone, the uterine lining changes to prepare for potential implantation of an embryo to establish a pregnancy. If implantation does not occur within approximately two weeks, the corpus luteum will involute, causing a sharp drop in levels of both progesterone and estrogen.
Sex drive is dependent on androgen levels only in the presence of estrogen, but without estrogen, free testosterone level actually decreases sexual desire (instead of increases sex drive), as demonstrated for those women who have hypoactive sexual desire disorder, and the sexual desire in these women can be restored by administration of estrogen (using oral contraceptive). in non-human mammals, mating desire is triggered by estrogen surge in estrus.
Estrogen also influences:
Endogenous estrogens and estrogen metabolites play an important role in the pathogenesis and development of human breast, endometrial, and ovarian cancers. Increasing evidence also supports their involvement in the development of certain lung, colon and prostate cancers.
Some studies have suggested that estrogen may be involved in the development of skin cancer as skin keratinocytes possess estrogen receptors (ERs), and oral contraceptives and hormone therapy decrease acne and skin aging, respectively. Epidemiological studies examining associations between hormone therapy and melanoma risk have not been entirely conclusive, although some studies have shown a link between hormone use and increased risk of melanoma. Epidemiologically, estrogens have also been linked to colon cancer, as men are more likely to develop this disease and hormone replacement therapy has been shown to reduce the risk of this cancer in women.
Hypoestrogenism (estrogen deficiency)
Estrogen plays a principal role in skeletal growth and bone homeostasis. In women, estrogen deficiency after menopause accelerates frequently osteoclastic bone resorption. It was believed that the accelerated phase in women is most apparent during the first 3 to 5 years after menopause, involved unproportional loss of bone.
Estrogen suppresses both directly and indirectly bone resorption. Finally, estrogen is important for the maintenance of bone formation. Human studies show that acute (3 weeks) estrogen deficiency is associated with a fall in bone-formation markers. Chronically estrogen deficient increased both bone-resorption and bone-formation markers.
Several aspects of menopause are universal: hot flashes, excessive transpiration, and vaginal atrophy, caused by estrogen deficiency and manifested in most women after menopause. The systemic aspects of menopause are well documented and include oral manifestations, such as changes in salivary secretion, gingivitis, bleeding and altered taste sensation.
Hyperestrogenism (estrogen excess)
Hyperestrogenism can be caused by ovarian tumors, genetic conditions, or overconsumption of exogenous sources of estrogen, including medications used in hormone replacement therapy and hormonal contraception. Symptoms of the condition in women may consist of menstrual irregularities, amenorrhea, abnormal vaginal bleeding, and enlargement of the uterus and breasts. It may also present as isosexual precocity (puberty occurring at an unusually early age) in children and as hypogonadism ( a condition in which the body doesn't produce enough sex hormones), gynecomastia (enlargement of men’s breasts), feminization, impotence, and loss of libido in males. If left untreated, hyperestrogenism may increase the risk of estrogen-sensitive cancers such as breast cancer later in life.
Condition causing cervical mucus too thick and hostile to allow the sperm to penetrate the cervix.
Cancer that arises from the endometrium, the lining of the uterus.
Thickening of the lining of the uterus.
The finger like overgrowths attached to the inner wall of the uterus that extend into the uterine cavity which are made of endometrial tissue
A state in which pieces of the tissue alike to the lining of the uterus (endometrium) grow in other parts of the body.
The presence of abnormally high levels of prolactin in the blood.
A medical term which describes a diminished functional activity of the gonads – the testes and ovaries.
The time in most women's lives when menstrual periods stop permanently, and the woman is no longer able to have children.
A disease of excess body fat that can have a negative effect on health, leading to reduced life expectancy and other health problems.
Light or infrequent menstrual ﬂow at intervals of 39 days to 6 months or 5–7 cycles in a year.
Surgical removal of one or both ovaries.
A condition in which a woman has an imbalance of female sex hormones. This may lead to changes in the menstrual cycle, cysts in the ovaries, trouble g
The most common benign smooth muscle tumors of the uterus encountered in women of reproductive age.
A form of a congenital malformation where the uterine cavity is partitioned by a longitudinal septum. It is one of Müllerian duct anomalies.
A form of a congenital malformation where the uterus is partially divided by a longitudinal septum. It is one of Müllerian duct anomalies.
A physical or psychological condition in which woman cannot engage in any form of vaginal penetration.